NCT00622388 Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant Status COMPLETED Phase PHASE2
NCT00621894 Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation Status COMPLETED Phase PHASE2
NCT00621322 Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy Adults Status COMPLETED Phase PHASE2
NCT00619424 A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00616928 Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years Status COMPLETED Phase PHASE3
NCT00615524 Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer Status WITHDRAWN Phase PHASE2
NCT00615212 Effect of GSK376501 on CYP450 Activity in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT00614991 An Interaction Study to Assess Drug Levels in Healthy Adult Subjects Status COMPLETED Phase NA
NCT00614978 Lapatinib and Temozolomide for the Treatment of Progressive Brain Disease in HER-2 Positive Breast Cancer Status COMPLETED Phase PHASE1
NCT00614614 Immuno,Safety of GSK Vaccine 134612 Given at Age of 12-15 Months 15-18 Months Post-priming With GSK Vaccine 792014 Status COMPLETED Phase PHASE3
NCT00612820 A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR) Status COMPLETED Phase PHASE2
NCT00612456 To Evaluate the Pharmacodynamics, Safety, and Pharmacokinetics of Pazopanib Drops in Adult Subjects With Neovascular AMD Status COMPLETED Phase PHASE2
NCT00612118 A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis Status COMPLETED Phase PHASE2
NCT00611559 Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children Status COMPLETED Phase PHASE4
NCT00611468 Phase I, Dosage-finding and PK Study of IV Topotecan and Erlotinib With Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT00611455 Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy Status TERMINATED Phase PHASE3
NCT00610909 Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS) Status COMPLETED Phase PHASE4